Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Scotte

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paperTim Cooksley, Carme Font, Florian Scotte, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2020
How to manage patients with corticosteroids in oncology in the era of immunotherapy?Mihaela Aldea, Emeline Orillard, Laura Mansi, et al.
European Urology|July 1, 2008
Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapyDominique Helley, Eugeniu Banu, Abdelkader Bouziane, et al.
Expert Review of Anticancer Therapy|June 6, 2009
Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinomaStéphane Oudard, Jacques Medioni, Jorge Aylllon, et al.
BMJ Supportive & Palliative Care|February 22, 2023
COVID-19 impact on an oncologic emergency department visits: observational studyAurélie Ram, Arnaud Pagès, Edouard Cubilier, et al.
BMJ Supportive & Palliative Care|August 29, 2020
Using targeted therapies at the end of lifeMatthieu Delaye, Florian Scotte, Sabine Voisin-Saltiel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2024
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patientsMary Lou Affronti, Jiyeon Lee, Alex Molassiotis, et al.
BMJ Supportive & Palliative Care|October 28, 2021
Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experimentFlorian Scotte, Hélène Simon, Philippe Laplaige, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemiaLuiz H Arantes, Jeffrey Crawford, Pere Gascon, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paperTim Cooksley, Carme Font, Florian Scotte, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2020
How to manage patients with corticosteroids in oncology in the era of immunotherapy?Mihaela Aldea, Emeline Orillard, Laura Mansi, et al.
European Urology|July 1, 2008
Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapyDominique Helley, Eugeniu Banu, Abdelkader Bouziane, et al.
Expert Review of Anticancer Therapy|June 6, 2009
Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinomaStéphane Oudard, Jacques Medioni, Jorge Aylllon, et al.
BMJ Supportive & Palliative Care|February 22, 2023
COVID-19 impact on an oncologic emergency department visits: observational studyAurélie Ram, Arnaud Pagès, Edouard Cubilier, et al.
BMJ Supportive & Palliative Care|August 29, 2020
Using targeted therapies at the end of lifeMatthieu Delaye, Florian Scotte, Sabine Voisin-Saltiel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2024
MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patientsMary Lou Affronti, Jiyeon Lee, Alex Molassiotis, et al.
BMJ Supportive & Palliative Care|October 28, 2021
Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experimentFlorian Scotte, Hélène Simon, Philippe Laplaige, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemiaLuiz H Arantes, Jeffrey Crawford, Pere Gascon, et al.
Pageof 5